These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 21310281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J.
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [Abstract] [Full Text] [Related]

  • 3. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH, Sayed GH, Hussien MM, Shaaban MM.
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [Abstract] [Full Text] [Related]

  • 5. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Tjalma WA, Trinh XB, van Dam PA.
    Obstet Gynecol; 2006 Jan; 107(1):207-8; author reply 208. PubMed ID: 16394064
    [No Abstract] [Full Text] [Related]

  • 6. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P, Amant F, Poppe W, Van den Broecke R.
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA, Feldblum PJ, Raymond EG.
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [Abstract] [Full Text] [Related]

  • 9. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K, Reed S, Moehner S, Minh TD.
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [Abstract] [Full Text] [Related]

  • 10. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W, de Nazaré Silva dos Santos P, Correia VM, Borges L, Bahamondes L.
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [Abstract] [Full Text] [Related]

  • 11. [Reasons for removal of intrauterine devices among women in general practice].
    Kolding L, Majeed HG.
    Ugeskr Laeger; 2013 Mar 25; 175(13):884-6. PubMed ID: 23582897
    [Abstract] [Full Text] [Related]

  • 12. Use of the levonorgestrel-releasing intrauterine system and breast cancer.
    Backman T, Rauramo I, Jaakkola K, Inki P, Vaahtera K, Launonen A, Koskenvuo M.
    Obstet Gynecol; 2005 Oct 25; 106(4):813-7. PubMed ID: 16199640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
    Kaislasuo J, Suhonen S, Gissler M, Lähteenmäki P, Heikinheimo O.
    Hum Reprod; 2012 Sep 25; 27(9):2658-63. PubMed ID: 22763376
    [Abstract] [Full Text] [Related]

  • 15. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun 25; 18(101):125-30. PubMed ID: 19637436
    [Abstract] [Full Text] [Related]

  • 16. IUDs and ectopic pregnancy.
    Sivin I.
    Contraception; 1995 Nov 25; 52(5):321-2. PubMed ID: 8585891
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT, Souza JP, Andrade GN, Rowe PJ, Wildemeersch D.
    Contraception; 2004 Aug 25; 70(2):173-7. PubMed ID: 15288225
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.